The whole loop, one platform
Chart ingest → rules + AI flags → prescriber/DON e-sign → QBO invoice. No exporting, no separate signing tool, no month-end invoicing scramble.
Consultant pharmacist software
Consultant pharmacist software for SNF medication reviews — and ASC and dialysis.
One platform for the whole monthly engagement: ingest the charts, run the clinical rules, e-sign the recommendations, and invoice — without stitching together three tools.
Built for how consultant pharmacists actually work
SNF, ASC and dialysis
Medication regimen reviews plus AAAHC/DEA/vaccine-temp and CMS CfC §494 audits — the same platform across your whole book.
Defensible by design
Every recommendation is aligned to ASCP/Beers/STOPP and CMS F-tag guidance and captured as a dated, e-signed record.
Scales with your caseload
Solo pharmacists move faster; firms standardize output across every pharmacist so growth doesn't mean a new hire for every contract.
Frequently asked questions
What does WeConsult Rx do for a consultant pharmacist?
It runs the entire monthly engagement: chart ingest from PointClickCare/EHR, a rules-and-AI clinical review aligned to ASCP/Beers/STOPP, prescriber and DON e-signature, and QuickBooks Online invoicing — for SNF medication regimen reviews plus ASC and dialysis compliance audits.
Does it work for a solo pharmacist and for a firm?
Both. Solo pharmacists cut time per review and get paid faster; firms get one standardized, defensible workflow across every pharmacist and facility, so throughput scales without adding audit risk.
Which settings does it cover?
Skilled nursing (SNF) medication regimen reviews, ambulatory surgical centers (AAAHC pharmacy, DEA, vaccine temp), and dialysis (CMS CfC 42 CFR 494, AAMI water) — on one platform.
Is resident data secure?
WeConsult Rx is built for a HIPAA-conscious workflow with a BAA available, and demos use synthetic data only — never real PHI.
One platform for the whole month
See a live monthly review from chart ingest to invoice, or start with a free first-facility review.